POST Online Media Lite Edition


Paladin names Jonathan Ross Goodman as chairman of the board

Staff writer |
Montreal, QC, Canada - May 29, 2012, Montreal, QC, Canada - Paladin Labs Inc., a specialty pharmaceutical company, announces the appointment of Jonathan Ross Goodman as chairman of the board of directors of Paladin.

Article continues below

Prior to founding Paladin, Mr.Goodman was the Vice President of Business Development at Pharmascience Inc., where he led Pharmascience's successful efforts to in-license new products and develop key corporate alliances with such companies as Eli Lilly, Schering, Novartis, Berlex, Alcon and Fournier. In addition, Mr. Goodman was a consultant with Bain & Company, a management consulting firm, and also worked in brand maangement for Procter & Gamble.

Mr. Goodman holds a B.A. with Great Distinction from McGill University and the London School of Economics with 1st Class Honours. Additionally, Mr. Goodman holds an LL.B. and M.B.A. from McGill. Mr. Goodman is a member of the Bars of New York and Massachusetts, is an Accredited Pharmaceutical Manufacturing Representative, is a sessional lecturer in entrepreneurship at McGill University and is a part-time faculty member of Concordia University.


Radisson appoints Pierre Beaudoin and Jeff Swinoga to board, Rahul Paul as CEO
DAVIDsTEA appoints Jane Silverstone Segal as chair
Resolute Forest Products appoints Duncan K. Davies as chairman
Pershimex Resources appoints Serge M. Racine to board
DAVIDsTEA appoints Frank Zitella as chief financial officer

What to read next

Jonathan Goodman to take CEO role at Toachi Mining
The Goodman Group: Shane Goodman took new posts
DecisionPoint Systems appoints Dave Goodman CFO